丽珠医药集团股份有限公司（股票代码：01513）于2026年6月1日发布截至2026年5月31日止的月报表。报告显示，本月公司已发行普通股总数与上月相比无增减变动，股本结构保持稳定。
根据公告，丽珠医药H股（股份代码：01513）上月底与本月底的已发行股份数均为299,807,117股，A股（于深圳证券交易所上市，股份代号：000513）上月底与本月底亦均为588,100,054股。法定/注册股本总额为人民币887,907,171元，公司当月并无新增发行、购回或注销股份，也无股份期权或股权激励计划变动。
公司确认已符合香港联交所的公眾持股量要求，并遵守上市规则及相关法律规定。本次公告由公司秘书刘宁签署。至本月底，丽珠医药股本总数保持不变。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.